News Center

Home page

Peak Report

News reports

Story of time

Release time:

2020-08-14

Story of Time

■ Jin Xi Factory Zhang Zhijian

Time flies. It seems that it is only a twinkling of an eye that I have been in peak for 20 years. In the past 20 years, I have been working, studying and growing up. Little by little, my experience is the most precious wealth in my life.

In 1996 5 , I was lucky enough to be a member of the peak. I came to Jinguo Cement Plant (later Jinma Cement Plant) and was assigned to the coal mill position in the firing workshop. The production line of Jinguo Cement Plant was the first batch of rotary kilns in Zhejiang Province. At that time, the equipment was still being debugged. On the second day of work, I received the task of adding steel balls to the ball mill. When I saw that pile of steel balls, I was dumbfounded -- it was so heavy, so big, when would it be added? Fortunately, the squad leader had a way to lead us to line up between the mill and the ball pile, and put the steel balls into the machine one by one. After a busy morning, after a hastily finished lunch, everyone moved it again without taking a rest. I was busy until I got off work and finally finished the task. Although everyone was tired, they were all very happy because the trial production was about to ignite. Now I think of the joy of everyone when the ignition was successful, it seems like yesterday.

worked in the cement factory for less than a year, 1997 3 , I was transferred to Jianfeng Kangjie Chemical Co., Ltd., which was later Jiangnan Pharmaceutical Branch. The pharmaceutical factory has a beautiful environment, a high degree of automation in the production line, and it works indoors and has air conditioning, which is incomparable to the cement factory at that time. I made up my mind to work hard and live up to the company's trust.

In 2004 , the factory assigned me to be responsible for the procurement of raw materials. At that time, due to changes in the general environment, drug prices were repeatedly lowered. To control production costs, it was the most direct and important way to purchase raw and auxiliary materials. For this reason, I bargain with the supplier again and again, and try my best to "compress" the price under the premise of ensuring the quality. After hard work, only two raw materials, cefuroxime sodium and azithromycin, saved the purchase cost of ,200 yuan that year. However, good things took a long time. In that year, the company's funds were relatively tight, and sometimes the payment for goods was not timely enough. I tried every possible means to negotiate with the suppliers to win their understanding and support, extend the payment period, and ease the financial pressure in the factory.

In 2005 , the sales volume of cefmenoxime for injection, the main product, was increasing, and the amount of wastewater generated by production was also increasing, far exceeding the treatment capacity of the environmental protection facilities of Jiangnan Factory at that time, so it could only be pulled to Qiubin Pharmaceutical Factory for sewage treatment. Waste water 50 kg is a big barrel. Jiang Guomin and I are carrying, loading and unloading together, every day. The smell of waste water is very strong, it is disgusting to smell, and it is even more uncomfortable to splash on clothes and trousers, and it is even more unbearable in summer. However, we did not complain at all and handled it properly in time to ensure that the factory passed the environmental protection test smoothly. It was also that year that I was named the first gold medal employee by the group company.

In 2006 , I served as the warehouse monitor of Jiangnan Factory. Warehouse management is very trivial. As long as I have time, I will soak in the warehouse to check the storage and quality of various materials, and report problems to relevant departments in time. On one occasion, the azithromycin packing box sent by the printing factory was mistakenly printed as "Qi". After finding the problem, I immediately contacted the manufacturer to return it and redo it. In the management of pharmaceutical production GMP , the warehouse is also a very important link, so together with the warehouse keeper, I did a good job in the acceptance, warehousing, storage and distribution of materials in strict accordance with the specifications, and successfully passed the previous certification inspection. In normal work, if we find that there are raw and auxiliary materials, packaging materials or finished product quality inspection forms that have not arrived, we should also do a good job in linking up with the laboratory work. On one occasion, a batch of cefmenoxime had to be delivered in a hurry, but the quality inspection form was not yet in place. I contacted the central laboratory and learned that it had been opened. I rode my bike to get it back immediately without delaying the delivery.

From Jinguo Cement Company to Kangjie Chemical Company, and from Jiangnan Factory to Jinxi Factory now, along the way, I have witnessed the ups and downs in the process of peak development, tears and laughter, confusion and emotion, but what is more in my heart is a persistence-persisting in studying and striving to improve my business level. Adhere to strict demands on yourself, do every job well in a down-to-earth and conscientious manner. The spirit of "unity and struggle, truth-seeking and innovation, determination to rise to the top and climb the peak forever" promotes the continuous development of the peak cause and makes me grow up with the peak.

More information

Yunnan peak through the safety standard secondary acceptance

On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate

2020

07-30

Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory

News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Accident-free factory creation enters "second season"

At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open

2020

07-31

What will the Chinese Medicine Act bring us?

At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.

2020

07-31

< 1...49 50 51...61 > 跳转到页